Corindus Announces FDA Submission for Neurovascular Intervention Indication for CorPath® GRX Vascular Robotic System 14/02/201914/02/2019 by Thanasis Chalikias, posted in Έρευνες/Κλινικές Μελέτες, Επιστημονικά Νέα, Marketing/Managment, News Corindus Announces FDA Submission for Neurovascular Intervention Indication for CorPath® GRX Vascular Robotic System
You must be logged in to post a comment.